Invitae joins NIH-sponsored study aimed at improving understanding of the links between genes and cancer, heart disease and other conditions SAN FRANCISCO, April 8, 2021 /PRNewswire/ — Invitae...read more
Category - Next generation sequencing
Invitae to acquire Genosity to accelerate access to personalized oncology testing worldwide
Acquisition to support the speed, efficiency and flexibility needed for mainstream global adoption of personalized cancer care and monitoring SAN FRANCISCO, April 5, 2021 /PRNewswire/ — Invitae (NYSE: NVTA)...read more
The medical research community has a duty to be racially and ethnically inclusive in their study demographics
I am currently a third year undergraduate student at Emory University studying Biology and Religion while on the pre-med track. I am also presently the Digital Marketing and Communications Intern at enlightenbio due to...read more
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic...read more
